These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15502323)

  • 1. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis.
    Kammerer S; Germain P; Flaig R; Peluso-Iltis C; Mitschler A; Rochel N; Gronemeyer H; Moras D
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2048-50. PubMed ID: 15502323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
    Klaholz BP; Mitschler A; Moras D
    J Mol Biol; 2000 Sep; 302(1):155-70. PubMed ID: 10964567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor.
    Bourguet W; Ruff M; Bonnier D; Granger F; Boeglin M; Chambon P; Moras D; Gronemeyer H
    Protein Expr Purif; 1995 Oct; 6(5):604-8. PubMed ID: 8535152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid.
    Rochel N; Renaud JP; Ruff M; Vivat V; Granger F; Bonnier D; Lerouge T; Chambon P; Gronemeyer H; Moras D
    Biochem Biophys Res Commun; 1997 Jan; 230(2):293-6. PubMed ID: 9016769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
    Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
    Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
    Germain P; Iyer J; Zechel C; Gronemeyer H
    Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression, purification, and crystal structure of native ER alpha LBD.
    Eiler S; Gangloff M; Duclaud S; Moras D; Ruff M
    Protein Expr Purif; 2001 Jul; 22(2):165-73. PubMed ID: 11437591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization and preliminary crystallographic studies of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain.
    Razeto A; Pfitzner E; Becker S
    Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):550-2. PubMed ID: 14993689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
    Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
    Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization, and preliminary X-ray diffraction analysis.
    Bourguet W; Andry V; Iltis C; Klaholz B; Potier N; Van Dorsselaer A; Chambon P; Gronemeyer H; Moras D
    Protein Expr Purif; 2000 Jul; 19(2):284-8. PubMed ID: 10873543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
    Shiau AK; Barstad D; Radek JT; Meyers MJ; Nettles KW; Katzenellenbogen BS; Katzenellenbogen JA; Agard DA; Greene GL
    Nat Struct Biol; 2002 May; 9(5):359-64. PubMed ID: 11953755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization and preliminary X-ray diffraction studies of isoform alpha1 of the human thyroid hormone receptor ligand-binding domain.
    Nunes FM; Aparicio R; Santos MA; Portugal RV; Dias SM; Neves FA; Simeoni LA; Baxter JD; Webb P; Polikarpov I
    Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1867-70. PubMed ID: 15388935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a novel tetrameric complex of agonist-bound ligand-binding domain of Biomphalaria glabrata retinoid X receptor.
    de Groot A; de Rosny E; Juillan-Binard C; Ferrer JL; Laudet V; Pierce RJ; Pebay-Peyroula E; Fontecilla-Camps JC; Borel F
    J Mol Biol; 2005 Dec; 354(4):841-53. PubMed ID: 16274693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists.
    Alvarez S; Alvarez R; Khanwalkar H; Germain P; Lemaire G; Rodríguez-Barrios F; Gronemeyer H; de Lera AR
    Bioorg Med Chem; 2009 Jul; 17(13):4345-59. PubMed ID: 19482478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability.
    Wang W; Prosise WW; Chen J; Taremi SS; Le HV; Madison V; Cui X; Thomas A; Cheng KC; Lesburg CA
    Protein Eng Des Sel; 2008 Jul; 21(7):425-33. PubMed ID: 18456871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of human TSG101 UEV domain.
    Palencia A; Martinez JC; Mateo PL; Luque I; Camara-Artigas A
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):458-64. PubMed ID: 16552148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid.
    Egea PF; Mitschler A; Rochel N; Ruff M; Chambon P; Moras D
    EMBO J; 2000 Jun; 19(11):2592-601. PubMed ID: 10835357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
    Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
    Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.